Litcius/Paper detail

MAP kinase inhibitor PD98059 regulates Th1, Th9, Th17, and natural T regulatory cells in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis

Sheikh F. Ahmad, Mushtaq Ahmad Ansari, Ahmed Nadeem, Saleh A. Bakheet, Abdullah F. Alasmari, Mudassar Shahid, Haneen A. Al‐Mazroua, Hatun A. Alomar, Homood M. AsSobeai, Ali A. Alshamrani, Sabry M. Attia

2023European Journal of Pharmacology13 citationsDOI

Topics & Concepts

RAR-related orphan receptor gammaFOXP3Experimental autoimmune encephalomyelitisIRF4ImmunologyInterleukin 17AutoimmunityBiologyCancer researchInflammationImmune systemTranscription factorGeneBiochemistryCytokine Signaling Pathways and InteractionsMelanoma and MAPK PathwaysPharmacological Effects of Natural Compounds
MAP kinase inhibitor PD98059 regulates Th1, Th9, Th17, and natural T regulatory cells in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis | Litcius